ResearcherPurdue University West LafayetteNo recent work listed
Xiaoqi Liu
Matched on ORCID iD 0000-0002-6613-1746, 0000-0002-7038-333X; OpenAlex author ID A5100740693. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 5
- Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. Last author DOI 10.1158/0008-5472.can-22-0018↗
- SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12920-020-0681-6↗
- Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Co-author DOI 10.1038/onc.2016.168↗
- Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer. Last author DOI 10.1080/15384101.2016.1148838↗
- Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. Last author DOI 10.1158/1535-7163.mct-12-0632↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen F Konieczny · 4 shared papers, 2013–2022 · strength 0.27
- Paper Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. DOI 10.1158/0008-5472.can-22-0018↗
- Paper Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer. DOI 10.1080/15384101.2016.1148838↗
- Paper Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. DOI 10.1038/onc.2016.168↗
- Lijun Cheng · 2 shared papers, 2020–2022 · strength 0.27
- Zhuangzhuang Zhang · 2 shared papers, 2020–2022 · strength 0.27
- Enze Liu · 1 shared paper, 2020 · strength 0.15
- Patrick G. Schweickert · 1 shared paper, 2016 · strength 0.06
- Yi Yang · 1 shared paper, 2016 · strength 0.06
- Jie Li · 1 shared paper, 2016 · strength 0.06
- Nihal Ahmad · 1 shared paper, 2016 · strength 0.06
- J-X Cheng · 1 shared paper, 2016 · strength 0.05
- Shaoxiong Chen · 1 shared paper, 2016 · strength 0.05
- Dongsheng Gu · 1 shared paper, 2016 · strength 0.05
- Junjie Li · 1 shared paper, 2016 · strength 0.05
- Jingwu Xie · 1 shared paper, 2016 · strength 0.05
- Tony Hazbun · 1 shared paper, 2013 · strength 0.03
- Bing Song · 1 shared paper, 2013 · strength 0.03
- Elena Gabriela Chiorean · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.